Back
Sarepta Therapeutics Vs. Texas Pacific Land Industry Stock Comparison
Sell
33
SRPT
Sarepta Therapeutics
Last Price:
114.28
Seasonality Move:
16.38%
Buy
69
TPL
Texas Pacific Land
Last Price:
1,731.72
Seasonality Move:
5.54%
Sell
33
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $114.23. The Score for SRPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
69
Texas Pacific Land (TPL)
is a Buy
Is Texas Pacific Land a Buy, Sell or Hold?
- The current Texas Pacific Land [TPL] share price is $1,730.00. The Score for TPL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- TPL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $114.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
TPL Stock Price Chart
What is Texas Pacific Land's stock price today?
-
The Texas Pacific Land share price today is $1,730.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TPL is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.42 | Sell |
| Relative Strength Index (14 RSI): | 44.35 | Sell |
| Chaikin Money Flow: | 638386 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (111.48 - 129.26) | Sell |
| Bollinger Bands (100): | (119.5 - 143.18) | Sell |
TPL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 127.94 | Buy |
| Relative Strength Index (14 RSI): | 92.1 | Buy |
| Chaikin Money Flow: | 559044 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1115.8 - 1446.52) | Buy |
| Bollinger Bands (100): | (749.53 - 1176.17) | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 109.13 | Buy |
| 20-day SMA: | 118.03 | Sell |
| 50-day SMA: | 122 | Sell |
| 200-day SMA: | 130.03 | Sell |
| 8-day EMA: | 111.53 | Buy |
| 20-day EMA: | 115.85 | Sell |
| 50-day EMA: | 121.84 | Sell |
| 200-day EMA: | 126.04 | Sell |
TPL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1450.33 | Buy |
| 20-day SMA: | 1329.52 | Buy |
| 50-day SMA: | 1115.06 | Buy |
| 200-day SMA: | 778.77 | Buy |
| 8-day EMA: | 1485.56 | Buy |
| 20-day EMA: | 1353.69 | Buy |
| 50-day EMA: | 1170.74 | Buy |
| 200-day EMA: | 861.48 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.72 per share.
Texas Pacific Land Earnings Growth & TPL Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.73 per share, and an increase next year of $2.99 per share.
Sarepta Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Texas Pacific Land Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||